Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Related posts
-
Transit’s fiscal cliff gets steeper as leaders warn of ‘death spiral’
Metra, Pace and the CTA delivered their 2025 budgets to the RTA Friday but the big... -
Student-designed nutcrackers on display this weekend in Rosemont
More than two dozen human-sized nutcrackers sculptures custom painted by high school students went on display... -
All on board: Bensenville rallies behind food pantry after holiday train schedule change
Bensenville rallied to collect money and items for a community food pantry after learning a holiday...